A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®

• Status: Completed
• Trial end date: 2006-02-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is designed to compare skin reactions with or without the use of warm compress prior to performing a Copaxone® injection.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Teva Neuroscience, Inc.; Teva Pharmaceutical Industries
• Treatments: (T,G)-A-L; Glatiramer Acetate

Criteria

Inclusion Criteria:

1. Male or Female, 18 years or older, with a diagnosis of RRMS

2. Willing and able to complete all procedures and evaluations related to the study.

3. Willing to provide Informed Consent

Exclusion Criteria:

1. Taking any other immunomodulatory therapy in conjunction with Copaxone®.

2. Has a significant medical illness other than MS which may interfere with the assessment of endpoints or the subject's participation in the trial for the full duration of the study.

3. Any situation which the investigator or nurse feels may interfere with participation in the study.

4. Pregnant, or trying to become pregnant, or breast feeding during the study.

5. Previously participated in this study.